Literature DB >> 6164911

The inhibition of DNA(cytosine-5)methylases by 5-azacytidine. The effect of azacytosine-containing DNA.

S Friedman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6164911

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  27 in total

1.  Binding of the EcoRII methyltransferase to 5-fluorocytosine-containing DNA. Isolation of a bound peptide.

Authors:  S Friedman; N Ansari
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

2.  Chemical synthesis of 2'-deoxyoligonucleotides containing 5-fluoro-2'-deoxycytidine.

Authors:  S Schmidt; C D Pein; H J Fritz; D Cech
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

3.  Binding of the EcoRII methylase to azacytosine-containing DNA.

Authors:  S Friedman
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

4.  The mechanism of inhibition of DNA (cytosine-5-)-methyltransferases by 5-azacytosine is likely to involve methyl transfer to the inhibitor.

Authors:  S Gabbara; A S Bhagwat
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

5.  5-Azacytidine (NSC 102816) in refractory germ cell tumors. A phase II trial of the Eastern Cooperative Oncology Group.

Authors:  B J Roth; P Elson; G W Sledge; L H Einhorn; D L Trump
Journal:  Invest New Drugs       Date:  1993 May-Aug       Impact factor: 3.850

6.  Nucleotide sequence and expression of the gene encoding the EcoRII modification enzyme.

Authors:  S Som; A S Bhagwat; S Friedman
Journal:  Nucleic Acids Res       Date:  1987-01-12       Impact factor: 16.971

7.  Pharmacodynamic and DNA methylation studies of high-dose 1-beta-D-arabinofuranosyl cytosine before and after in vivo 5-azacytidine treatment in pediatric patients with refractory acute lymphocytic leukemia.

Authors:  V I Avramis; R A Mecum; J Nyce; D A Steele; J S Holcenberg
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

8.  A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis.

Authors:  A Quintás-Cardama; W Tong; H Kantarjian; D Thomas; F Ravandi; S Kornblau; T Manshouri; J E Cortes; G Garcia-Manero; S Verstovsek
Journal:  Leukemia       Date:  2008-04-03       Impact factor: 11.528

9.  Induction of EcoRII methyltransferase: evidence for autogenous control.

Authors:  S Friedman; S Som
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

10.  Hemimethylated duplex DNAs prepared from 5-azacytidine-treated cells.

Authors:  P A Jones; S M Taylor
Journal:  Nucleic Acids Res       Date:  1981-06-25       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.